Pre-market open on 3/20/25, Adaptimmune (NASDAQ:ADAP) provided a business update for 4Q24 (in lieu of financial results for the quarter/full year to be released in conjunction with the company’s 10-K ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback